16.2EGP
- Active ingredient
- ethambutol+isoniazid+pyrazinamide+rifampicin
- Form
- tablet
- Manufacturer
- international drug agency (idi)
- Route
- oral.solid
Uses
Used for treatment of active tuberculosis as part of combination therapy.
Do not use if
Severe liver disease, hypersensitivity to any component, or optic neuritis.
Side effects
Hepatotoxicity, gastrointestinal upset, rash, visual disturbances, and arthralgia may occur.
Warnings
Monitor liver function and adherence to therapy.
How it works
Combines four antitubercular agents targeting different bacterial pathways.
Storage
Store below 25°C.